Privia Health Group, Inc. (PRVA)
NASDAQ: PRVA · Real-Time Price · USD
23.75
-1.16 (-4.66%)
Feb 27, 2026, 4:00 PM EST - Market closed
Privia Health Group Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Privia Health Group stock have an average target of 30.57, with a low estimate of 23 and a high estimate of 36. The average target predicts an increase of 28.72% from the current stock price of 23.75.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Privia Health Group stock from 14 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $34 → $35 | Strong Buy | Maintains | $34 → $35 | +47.37% | Feb 27, 2026 |
| RBC Capital | RBC Capital | Buy Initiates $31 | Buy | Initiates | $31 | +30.53% | Jan 9, 2026 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $32 | Buy | Reiterates | $32 | +34.74% | Dec 4, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $32 → $33 | Buy | Maintains | $32 → $33 | +38.95% | Nov 13, 2025 |
| BMO Capital | BMO Capital | Buy Initiates $30 | Buy | Initiates | $30 | +26.32% | Nov 13, 2025 |
Financial Forecast
Revenue This Year
2.43B
from 2.12B
Increased by 14.37%
Revenue Next Year
2.65B
from 2.43B
Increased by 8.94%
EPS This Year
0.32
from 0.18
Increased by 78.82%
EPS Next Year
0.45
from 0.32
Increased by 39.78%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.0B | 2.9B | |||
| Avg | 2.4B | 2.6B | |||
| Low | 2.0B | 2.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 89.7% | 18.0% | |||
| Avg | 14.4% | 8.9% | |||
| Low | -6.4% | -0.9% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 0.45 | 0.60 |
| Avg | 0.32 | 0.45 |
| Low | 0.14 | 0.34 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | 150.8% | 85.9% |
| Avg | 78.8% | 39.8% |
| Low | -23.8% | 6.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.